PATH | VRL
Menu

Find resources

Total results with these characteristics: 1323

Topic: Disease/vaccine specific information

Page 4 of 67
Beyond Efficacy: The Full Public Health Impact of Vaccines

This conference report, published in Vaccine, describes an active discussion in the public health community on how to assess and incorporate, in addition to safety and measures of protective efficacy, the full public health value of preventive …

Author: Saadatian-Elahi M, Horstick O, Breiman RF, et al.

Publication date: 2016

Beyond Eradication: The United States’ Role in Sustaining Public Health Gains Achieved Through Polio Programs

This report provides analysis and policy recommendations for the US government to protect the public health gains made as a result of polio eradication through technical and financial resources.

Author: PATH

Publication date: 2016

Biological Challenges and Technological Opportunities for Respiratory Syncytial Virus Vaccine Development

This article, published in Immunological Reviews, provides an overview of the barriers that have challenged and delayed the development of vaccines against respiratory syncytial virus (RSV) and identifies opportunities that could help overcome these …

Author: Graham B

Publication date: 2011

The Biological Function of Antibodies Induced by the RTS,S/AS01 Malaria Vaccine Candidate is Determined by Their Fine Specificity

This article, published in Malaria Journal, discusses how recent vaccine studies have shown that the magnitude of an antibody response is often insufficient to explain efficacy, suggesting that characteristics regarding the quality of the …

Author: Chaudhury S, Ockenhouse CF, Regules JA, et al.

Publication date: 2016

The Bourgeoning Burden of Respiratory Syncytial Virus Among Children

This article, published in Infectious Disorders – Drug Targets, examines the disease burden of respiratory syncytial virus (RSV) in the United States, Canada, and Europe, but notes that the global burden of RSV is unknown as few studies are from …

Author: Hall CB

Publication date: 2012

Breakeven Analysis for Various Human Papillomavirus Vaccine Presentations in Vietnam and Uganda

This report highlights a study that uses a breakeven cost analysis to compare potential prices, wastage rates, and cold chain requirements for various human papillomavirus vaccine presentations. The results of this study provide insight into …

Author: PATH, World Health Organization

Publication date: 2010

Breaking the Cycle With Vaccines: The Malaria Life Cycle

This graphic displays the malaria parasite's life cycle and highlights where three different types of vaccines could interrupt various stages of the life cycle.

Author: PATH

Broadening the Age Restriction for Initiating Rotavirus Vaccination in Regions With High Rotavirus Mortality: Benefits of Mortality Reduction Versus Risk of Fatal Intussusception

This article, published in Vaccine, reports on a study that assessed the potential benefits of mortality reduction versus the risk of fatal intussusception when (a) the first dose of rotavirus vaccine was administered by 12 weeks of age compared …

Author: Patel MM, Clark AD, Glass RI, et al.

Publication date: 2009

Broadly Protective Protein-Based Pneumococcal Vaccine Composed of Pneumolysin Toxoid-CbpA Peptide Recombinant Fusion Protein

Pneumococcus, meningococcus and Haemophilus influenzae cause a similar spectrum of infections in the ear, lung, blood, and brain. They share cross-reactive antigens that bind to the laminin receptor of the blood-brain barrier as a molecular basis …

Author: Mann B, Thornton J, Heath R, et al.

Publication date: 2013

Building an Effective Malaria Vaccine Portfolio to Address Global Needs

This article, published in Vaccine, examines the research and development pipeline of malaria vaccines. It reviews the latest information on financing, vaccine commercialization, controlled human malaria infection models, and the regulatory …

Author: Birkett AJ

Publication date: 2015

Burden and Aetiology of Diarrhoeal Disease in Infants and Young Children in Developing Countries (the Global Enteric Multicenter Study, GEMS): A Prospective, Case-Control Study

This article, published in The Lancet, reports on results of the Global Enteric Multicenter Study (GEMS), which was designed to identify the aetiology and population-based burden of pediatric diarrheal disease in sub-Saharan Africa and south Asia. …

Author: Kotloff KL, Nataro JP, Blackwelder WC, et al.

Publication date: 2013

The Burden of Cervical Cancer in Vietnam: Synthesis of the Evidence

This article, published in Cancer Epidemiology, reports the results of a study to synthesize available data on the burden of human papillomavirus (HPV) disease and to project the burden of cervical cancer to 2049 if no major interventions are …

Author: Nguyen DNT, Simms K, Nguyen HQV, et al.

Publication date: 2019

The Burden of Childhood Pneumonia in the Developed World: A Review of the Literature

This article, published in The Pediatric Infectious Disease Journal, provides disease burden estimates of pneumonia incidence in the developed world in children under five years of age. Available estimates suggest that each year there are up to 2.6 …

Author: Madhi SA, Wals PD, Grijalva CG, et al.

Publication date: 2013

Burden of Disease Caused by Streptococcus Pneumoniae in Children Younger than 5 Years: Global Estimates

This article, published in The Lancet, releases new global burden of disease data for Streptococcus pneumoniae (pneumococcus), a leading cause of bacterial pneumonia, meningitis, and sepsis in children worldwide. The results also include data at the …

Author: O'Brien KL, Wolfson LJ, Watt JP, et al.

Publication date: 2009

Burden of Enterotoxigenic Escherichia coli and Shigella Non-Fatal Diarrhoeal Infections in 79 Low-Income and Lower Middle-Income Countries: A Modelling Analysis

This article, published in the The Lancet Global Health, reports the results of a modelling study to estimate the effect of enterotoxigenic Escherichia coli (ETEC) and Shigella-related diarrhea on stunting and the associated mortality due to other …

Author: Anderson JD, Bagamian KH, Muhib F, et al.

Publication date: 2019

The Burden of Group B Streptococcus Worldwide for Pregnant Women, Stillbirths, and Children

This supplement to Clinical Infectious Diseases contains a collection of 11 articles related to group B Streptococcus (GBS) disease burden and surveillance among pregnant women and children globally. The articles within this supplement discuss …

Author: Seale A, Lawn J, eds.

Publication date: 2017

The Burden of JE in Southeast Asia: The Role of NGOs in the Fight Against the Disease

This presentation, given at the 2006 meeting of the American Society for Tropical Medicine and Hygiene, provides an overview of JE disease burden and the activities of the PATH JE project.

Author: PATH

Publication date: 2006

Burden of Paediatric Rotavirus Gastroenteritis (RVGE) and Potential Benefits of a Universal Rotavirus Vaccination Programme with a Pentavalent Vaccine in Spain

This study, published in BMC Public Health, assesses the health outcomes and the economic impact of a universal rotavirus vaccination program with RotaTeq, a pentavalent rotavirus vaccine, against a no vaccination program in Spain. The study …

Author: Diez-Domingo J, Surinach NL, Alcalde NM, Betegon L, Largeron N, Trichard M

Publication date: 2010

The Burden of Pneumococcal Disease Among Latin American and Caribbean Children: Review of the Evidence

This article, published in the Pan American Journal of Public Health, estimates the annual burden of pneumonia, meningitis, and acute otitis media caused by pneumococcus in children less than five years of age in Latin America and the Caribbean …

Author: Valenzuela MT, O'Loughlin R, De La Hoz F, et al.

Publication date: 2009

The Burden of Pneumococcal Disease and Cost-Effectiveness of a Pneumococcal Vaccine in Latin America and the Caribbean: A Review of the Evidence and a Preliminary Economic Analysis

This report estimates the burden and costs of pneumococcal disease in Latin America and the Caribbean in order to inform national health authorities about disease burden and the economic value of implementing a pneumococcal …

Author: Sabin Vaccine Institute

Publication date: 2007

Page 4 of 67